Miltenyi Biotec competitive analysis

Latest publications and patents of Miltenyi Biotec New

Explore the latest publications and patents granted to Miltenyi Biotec, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Miltenyi Biotec

Jan 2, 2019Method For Automated Generation Of Genetically Modified T CellsGranted And Under Opposition
Sep 26, 2018Combination Immunotherapy Of Antigen-Recognizing Receptors And Hematopoietic Cells For The Treatment Of DiseasesRevoked
Jan 24, 2018Sample Processing System And MethodsNo Opposition Filed Within Time Limit

Explore patent oppositions filed by Miltenyi Biotec against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Quantitative Dna-Based Imaging And Super-Resolution ImagingPRESIDENT AND FELLOWS OF HARVARD COLLEGESep 8, 2023
Point-Of-Care And/Or Portable Platform For Gene TherapyFRED HUTCHINSON CANCER RESEARCH CENTERFeb 1, 2022
CellAUTOLUSApr 8, 2020
Use Of Chimeric Antigen Receptor-Modified T Cells To Treat CancerTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJul 2, 2019
Method Of Reversibly Staining A Target CellIBAFeb 1, 2019
Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical ApplicationsGENETHONOct 9, 2018
Use Of An Antibody Directed Against A Membrane ProteinLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESFeb 9, 2018

Explore Miltenyi Biotec's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 2, 2019Method For Automated Generation Of Genetically Modified T Cells3
Sep 26, 2018Combination Immunotherapy Of Antigen-Recognizing Receptors And Hematopoietic Cells For The Treatment Of Diseases1

Latest PTAB cases involving Miltenyi Biotec

Discover the latest PTAB cases involving Miltenyi Biotec, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Miltenyi Biotec with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
MILTENYI BIOTEC64 - - Aggressive
AUTOLUS - 3 - - Non-Active
D YOUNG29 - - - Highly Aggressive
FRED HUTCHINSON CANCER RESEARCH CENTER - 13 - - Non-Active